REG - MyHealthChecked PLC - Launch of COVID-19 rapid antigen test service

MyhealthcheckedAnnouncement

24/11/2021 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211124:nRSX3344Ta&default-theme=true

RNS Number : 3344T  MyHealthChecked PLC  24 November 2021

MyHealthChecked PLC

("MyHealthChecked" or the "Company")

 

Launch of COVID-19 Day 2 rapid antigen test and verification service

 

MyHealthChecked Plc (AIM: MHC), announces the launch of two home testing
services for travellers entering and departing the UK. On 24 November the
company will begin selling a rapid antigen test and a verification service for
residents and vaccinated travellers arriving in England from a non-red list
country, followed by a Fit to Fly rapid test for travellers leaving the UK
launching next week.

 

The online service will allow customers to order a test before arriving into
England (where COVID-19 travel rules are different to those in Scotland, Wales
and Northern Ireland) or departing from the UK. The test can be taken at home
with results verified by a trained professional within 2 hours of completing
the test. Customers are then notified by email when the result is ready, and a
QR-code secured COVID-19 result certificate is made available for download.

 

The service will utilise the CE approved, ISO certified and UK Government
validated FlowFlex® Rapid Test Kit, a lateral flow test that is easy to
administer via a simple nasal swab, which provides results in 15 minutes and
offers 98.8% accuracy.

 

MyHealthChecked has also partnered with medical specialists Mediskills, who
will provide fully trained NHS professionals to verify test results as part of
this service. MyHealthChecked will have full responsibility for overseeing the
service, processing orders and dispatches, as well as warehousing test kit
stock. The Company will continue to maintain the high standards of customer
service already being delivered across its other testing services.

 

MyHealthChecked remains a high-quality laboratory provider but has adapted to
evolving market requirements, allowing the Company's reputation for delivering
a good customer experience and a reliable testing service across a wider
variety of testing formats.

 

Penny McCormick, Chief Executive Officer of MyHealthChecked PLC, commented: "I
am delighted to announce the launch our new COVID-19 Day 2 rapid antigen
testing service. Our agility in adapting to the changing market needs shows
the strength of our team, our digital platform, and our ability to offer
customers highly compliant testing services via on a digital platform that
gives a great user experience. Our focus on ensuring the best possible
customer service has already allowed us to meet the needs of our key retail
partners and has established a trusted relationship based on the best possible
service delivery."

 

 MyHealthChecked PLC                                                www.myhealthchecked.com (http://www.myhealthchecked.com/)
 Penny McCormick, Chief Executive Officer                           via Walbrook PR
 Gareth Davies, Chief Financial and Operations Officer

 SPARK Advisory Partners Limited (NOMAD)                            Tel: +44 (0)20 3368 3550
 Neil Baldwin

 Oberon Capital Ltd (Broker)                                        Tel: +44 (0)203 179 5344
 Mike Seabrook                                                      mikeseabrook@oberoninvestments.com (mailto:mikeseabrook@oberoninvestments.com)

 Walbrook PR Ltd (Media & IR)      Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
                                   (mailto:myhealthcheckedplc@walbrookpr.com)
 Paul McManus / Alice Woodings                                      Mob: +44(0)7980 541 893 / +44 (0)7407 804 654

 

 

About MyHealthChecked PLC (www.myhealthcheckedplc.com
(http://www.myhealthcheckedplc.com) )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK
healthcare company focused on a range of at-home healthcare and wellness
tests. MyHealthChecked is the umbrella brand of a range of at-home DNA and
RNA tests, now in development following the acquisition of The Genome Store in
November 2020. The tests will be made available online and would be viable for
over-the-counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in
mindset as customers become more familiar with the concept of accessible
healthcare in the growing at home testing kit market, with a focus on
accessibility at the right price, led by UK-based experts.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFLFLTLILVFIL